Table 1.
Author(s) | Title | Year of publication | Type of study | Number of patients | Inclusion criteria | Primary outcome | Type of antiplatelet drug used | Severity scoring | Timing of APT | Duration of maximum follow-up | Definition of ALI/ARDS | Definition of sepsis |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Winning et al.[35] | Antiplatelet drugs and outcome in severe infection: Clinical impact and underlying mechanisms | 2009 | Observational | 224 | Patients who were admitted to the hospital for CAP | Need for treatment in ICU Length of hospital stay | Aspirin, clopidogrel | SOFA 2.95±2.03 (control) versus 2.74±1.18 (APT) | Patients on APT for at least 6 months before admission | 28 days | ||
Winning et al.[34] | Antiplatelet drugs and outcome in mixed admissions to an ICU | 2010 | Observational | 615 | Patients admitted to the ICU within 24 h after arrival to the hospital | Death during ICU treatment or discharge from ICU | Aspirin, clopidogrel | APACHE II: 19 (13-19) (control) versus 25 (19-32) (APT) | Patients on APT before admission | Duration of ICU stay | ||
Erlich et al.[25] | Prehospitalization APT is associated with a reduced incidence of ALI | 2011 | Observational | 161 | Age>18 years+at least one risk factor for ALI (high-risk trauma, aspiration, sepsis, shock, pneumonia, and pancreatitis) | Development of ALI or ARDS during hospitalization | Aspirin, clopidogrel, ticlopidine, cilostazol, dipyridamole, anagrelide, persantine | APACHE III: 39 (27-54) (control) versus 46 (34-57) (APT) | Patients on APT before admission | American- European Consensus Conference criteria[40] | ||
Lösche et al.[50] | Do aspirin and other antiplatelet drugs reduce the mortality in critically ill patients? | 2012 | Observational | 224 | Patients admitted to the hospital with CAP | Length of hospital stay Admission to ICU | Aspirin, ticlopidine, clopidogrel | SOFA odds ratio 0.19 (0.04-0.87) | Patients on APT for at least 6 months before admission | Duration of hospital stay | ||
Lösche et al.[50] | Do Aspirin and other antiplatelet drugs reduce the mortality in critically ill patients? | 2012 | Observational | 834 | ICU admission for severe sepsis or septic shock | ICU mortality | Aspirin | APACHE II: 22.6±9.2 (control) versus 24.1±8.3 (APT) | Duration of ICU stay | |||
Eisen et al.[24] | Acetylsalicylic acid usage and mortality in critically ill patients with the SIRS and sepsis | 2012 | Observational | 2890 | Patients admitted to the ICU with SIRS | Hospital mortality | Aspirin | APACHE II: 17.78 (control) versus 17.47 (APT) | Patients on APT in the 24 h period at time of detection of SIRS | America College of Chest Physicians/Society of Critical Care Medicine Consensus Conference criteria[48] | ||
Losche et al.[29] | Association of prehospitalization aspirin therapy and ALI: results of a multicenter international observational study of at-risk patients | 2012 | Observational | 3855 | Admission to the hospital with the presence of at least one major risk factor for ALI and age>18 years.(aspiration, pneumonia, sepsis, shock, pancreatitis, high-risk trauma, or high-risk surgery) | Development of ALI/ARDS during hospitalization | Aspirin | APACHE II: 9 (5-14) (control) versus 12 (8-16) (APT) | Documentation of use or administration of APT at time of hospital admission | Duration of hospital stay | American- European Consensus Conference criteria[40] | |
Gross et al.[27] | Clopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of APT in pneumonia and critical illness | 2013 | Observational | 23,882 | Patients who received at least 6 consecutive prescriptions of clopidogrel | Incidence and severity of pneumonia | clopidogrel | NA | ≥6 prescription claims of APT | Duration of hospital stay | ||
Harr et al.[28] | APT is associated with decreased transfusion- associated risk of lung dysfunction, multiple organ failure, and mortality in trauma patients | 2013 | Observational | 839 | Blunt trauma mechanism, ED arrival within 6 h of injury, ED base deficit>6 mEq/L or ED systolic blood pressure<90 mm Hg, and a blood product transfusion within the first 12 h of ED arrival | Lung dysfunction defined by Denver lung dysfunction score of 2 or 3 Denver MOF score (>3) Mortality | Aspirin, ticlopidine, clopidogrel | NA | Patients on APT before trauma | 28 days | Denver lung dysfunction score Grades 2 or 3, which corresponds to PaO2:FiO2 ratio<200 | |
Valerio-Rojas et al.[33] | Outcomes of severe sepsis and septic shock patients on chronic antiplatelet treatment: A historical cohort study | 2013 | Observational | 651 | ≥18 years, diagnosis of severe sepsis or septic shock at the time of ICU admission and use of APT before admission | Hospital mortality | Aspirin, clopidogrel, ticlopidine, dipyridamole | APACHE III: 55 (42-68) (control) versus 57.5 (46-74.8) (APT) | Patients on APT at time of ICU admission | Duration of hospital stay | American- European Consensus Conference criteria[40] | America College of Chest Physicians/Society of Critical Care Medicine Consensus Conference criteria[48] |
Otto et al.[31] | Effects of low-dose acetylsalicylic acid and atherosclerotic vascular diseases on the outcome in patients with severe sepsis or septic shock | 2013 | Observational | 886 | Only patients with severe sepsis/septic shock and minimum ICU stay of 48 h | ICU mortality Discharge from ICU Hospital mortality | Aspirin, clopidogrel | NA | Patient on APT for at least 2 days during ICU stay | Duration of hospital stay | ||
Faverio et al.[26] | Antiplatelets improve survival among critically ill mechanically ventilated patients | 2014 | Observational | 150 | Critically ill mechanically ventilated patients for 1 day or more managed at a tertiary medical ICU | Mortality during ICU and hospital stay | Aspirin, clopidogrel | APACHE II>25 | Patient on prehospital or in-hospital APT | Duration of hospital stay | ||
Chen et al.[23] | Prehospital aspirin use is associated with reduced risk of ARDS in critically ill patients: A propensity- adjusted analysis | 2015 | Observational | 1149 | Patient who are 18 years old or older admitted to the medical, surgical, cardiovascular, and trauma ICUs who remained in the ICU for at least 2 days | ARDS in first 4 days of ICU stay | Aspirin | NA | Patients on APT before admission | Duration of hospital stay | American- European Consensus Conference criteria[40] | America College of Chest Physicians/Society of Critical Care Medicine Consensus Conference criteria[48] |
Tsai et al.[32] | Association of prior antiplatelet agents with mortality in sepsis patients: A nationwide population-based cohort study | 2015 | Observational | 683,421 | All patients with a first time discharge diagnosis of sepsis | In-hospital mortality from sepsis | Aspirin, clopidogrel, ticlopidine | NA | Patients on APT currently or within 30 days before admission | ICD 9 code for sepsis | ||
Mazzeffi et al.[30] | Preoperative aspirin use and lung injury after aortic valve replacement surgery: A retrospective cohort study | 2015 | Observational | 375 | All adult patients having aortic valve replacement surgery with cardiopulmonary bypass | Occurrence of ARDS | Aspirin | NA | Patients receiving preoperative APT | Berlin definition[67] | ||
Boyle et al.[22] | Aspirin therapy in patients with ARDS is associated with reduced ICU mortality: A prospective analysis | 2015 | Observational | 202 | All adult patients (>16 years-old) requiring invasive mechanical ventilation | ICU mortality | Aspirin | APACHE II: 18 (13-24) in (control) versus 21 (17-24) (APT) | Patients on prehospital APT, in ICU APT or both | Duration of hospital stay | American- European Consensus Conference criteria[40] | |
Al Harbi et al.[48] | Association between aspirin therapy and the outcome in critically ill patients: A nested cohort study | 2016 | Observational | 763 | ≥18-year-old with expected ICU length of stay of >48 h. Patients who were pregnant, had do-not-resuscitate status within 24 h of admission, were terminally ill or admitted to the ICU after cardiac arrest, seizures, liver transplantation, or burn injury were excluded | All cause ICU mortality and in-hospital mortality | Aspirin | APACHE II: 22.9±8.2 (control) versus 26.5±7.2 (APT) | Patients who had either continuation of a pre-ICU prescription or a newly prescribed APT in the ICU | Duration of ICU stay |
CAP: Community-acquired pneumonia, SIRS: Systemic inflammatory response syndrome, APACHE: Acute Physiology and Chronic Health Evaluation, SOFA: Sequential Organ Failure Assessment, APT: Antiplatelet therapy, NA: Not available, ICU: Intensive Care Unit, ALI: Acute lung injury, ARDS: Acute respiratory distress syndrome, ED: Emergency department